Case Challenges in

HIV Medicine

Benefits, Barriers, & Best Practices in an Advancing Field

Meeting Schedule


Consistent with CME practices related to the provision of modest meals at in-person educational programs, virtual meeting participants will receive an Uber Eats or Grubhub e-gift card to provide the same convenience for their participation. E-gift cards will be distributed following successful completion of the program evaluation form. The dollar amount provided on each e-gift card will be comparable to what is spent on an individual who attends an in-person meeting and, similarly, is subject to change based on the time of day a meeting is held.

Target Audience

This activity is designed to educate human immunodeficiency virus (HIV) specialists and infectious disease clinicians who are involved in the management of patients living with HIV.

Learning Objectives

Upon completion of this activity, the participant should be better able to:

  • Implement the most recent guidelines on identifying, treating, and monitoring patients with HIV
  • Describe the benefits of rapid antiretroviral therapy (ART) and tactics to overcome clinician and system barriers to implementation
  • Optimize ART selection for treatment initiation and medication switching according to patient characteristics and comorbidities

Program Description

Since the rapid initiation of antiretroviral therapy (ART) has become more widely available, identified barriers to more widespread adoption of this approach to HIV management—whether faced by patient, provider, or health care system—now need solutions. In this case-based symposium, Dr. Richard Elion, along with Drs. Eric Daar, Seble Kassaye, and Leandro Mena, will elucidate appropriate treatment approaches that integrate established, streamlined models of care and demonstrate optimal implementation of rapid ART. Faculty will guide learners on the important role of patient navigators or linkage to care coordinators in assisting patients to successfully enroll at the clinic, navigate public or private health insurance or drug assistance programs to gain access to ART, and get referrals for needed support services, including counseling or housing assistance. Demonstrating key considerations of HIV management through cases, faculty will identify and discuss aspects of care- (eg, comorbidities, polypharmacy issues, and adverse events) associated with ART regimens in specific subpopulations, such as women or the aging population. The proliferation of treatment-switching strategies has made therapeutic selection increasingly complex; real-world cases can provide context for education on this challenging topic.

As HIV care progresses and new treatment options become available for initiating and switching ART regimens, clinicians must know the data, indications, contraindications, and potential for adverse events or drug-drug interactions when individualizing treatment plans. Within the context of these interactive cases, faculty will share relevant guideline recommendations, newly published data, and their clinical expertise.


  • Opening Remarks and Preactivity Polling
  • Recent Updates to the Department of Health and Human Services (DHHS) HIV Guidelines
  • Rapid Antiretroviral Therapy (ART) Protocols as a New Standard of Care
  • Optimizing Adherence and Retention in Care Across Patient Types
  • Staying Up to Date in an Advancing Field
  • Audience Q&A


Richard A.
Elion, MD

Associate Clinical Professor
Department of Clinical Investigations
Whitman-Walker Health
The George Washington University
Washington, District of Columbia

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Chief, HIV Services
Lundquist Institute for Biomedical Innovation
Professor of Medicine
David Geffen School of Medicine
University of California, Los Angeles
Torrance, California

Seble G.
Kassaye, MD, MS

Associate Professor of Medicine
Department of Medicine
Division of Infectious Diseases
Georgetown University
Washington, District of Columbia

Leandro A.
Mena, MD, MPH

Chair and Professor of Population Health Science
Professor of Medicine
Division of Infectious Diseases
Director, Center for HIV/AIDS Research, Education and Policy
The University of Mississippi
Medical Center
Jackson, Mississippi

Accreditation Information

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Integritas Communications.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours.  Pharmacotherapy contact hours for Advanced Practice Registered Nurses to be determined.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are positioned to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COIs are thoroughly vetted and resolved according to PIM policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Fee Information

There is no fee for attending this program.